BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 31411782)

  • 1. Identification of the active site residues in ATP-citrate lyase's carboxy-terminal portion.
    Nguyen VH; Singh N; Medina A; Usón I; Fraser ME
    Protein Sci; 2019 Oct; 28(10):1840-1849. PubMed ID: 31411782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of ATP citrate lyase and the origin of citrate synthase in the Krebs cycle.
    Verschueren KHG; Blanchet C; Felix J; Dansercoer A; De Vos D; Bloch Y; Van Beeumen J; Svergun D; Gutsche I; Savvides SN; Verstraete K
    Nature; 2019 Apr; 568(7753):571-575. PubMed ID: 30944476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the citrate-binding site of human ATP-citrate lyase using X-ray crystallography.
    Sun T; Hayakawa K; Bateman KS; Fraser ME
    J Biol Chem; 2010 Aug; 285(35):27418-27428. PubMed ID: 20558738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ATP-citrate lyase multimerization is required for coenzyme-A substrate binding and catalysis.
    Bazilevsky GA; Affronti HC; Wei X; Campbell SL; Wellen KE; Marmorstein R
    J Biol Chem; 2019 May; 294(18):7259-7268. PubMed ID: 30877197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADP-Mg2+ bound to the ATP-grasp domain of ATP-citrate lyase.
    Sun T; Hayakawa K; Fraser ME
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2011 Oct; 67(Pt 10):1168-72. PubMed ID: 22102020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular basis for acetyl-CoA production by ATP-citrate lyase.
    Wei X; Schultz K; Bazilevsky GA; Vogt A; Marmorstein R
    Nat Struct Mol Biol; 2020 Jan; 27(1):33-41. PubMed ID: 31873304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Both subunits of ATP-citrate lyase from Chlorobium tepidum contribute to catalytic activity.
    Kim W; Tabita FR
    J Bacteriol; 2006 Sep; 188(18):6544-52. PubMed ID: 16952946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The structure of succinyl-CoA synthetase bound to the succinyl-phosphate intermediate clarifies the catalytic mechanism of ATP-citrate lyase.
    Huang J; Fraser ME
    Acta Crystallogr F Struct Biol Commun; 2022 Oct; 78(Pt 10):363-370. PubMed ID: 36189720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATP-citrate lyase from the green sulfur bacterium Chlorobium limicola is a heteromeric enzyme composed of two distinct gene products.
    Kanao T; Fukui T; Atomi H; Imanaka T
    Eur J Biochem; 2001 Mar; 268(6):1670-8. PubMed ID: 11248686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An allosteric mechanism for potent inhibition of human ATP-citrate lyase.
    Wei J; Leit S; Kuai J; Therrien E; Rafi S; Harwood HJ; DeLaBarre B; Tong L
    Nature; 2019 Apr; 568(7753):566-570. PubMed ID: 30944472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATP-citrate lyase: a mini-review.
    Chypre M; Zaidi N; Smans K
    Biochem Biophys Res Commun; 2012 May; 422(1):1-4. PubMed ID: 22575446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The reductive tricarboxylic acid cycle of carbon dioxide assimilation: initial studies and purification of ATP-citrate lyase from the green sulfur bacterium Chlorobium tepidum.
    Wahlund TM; Tabita FR
    J Bacteriol; 1997 Aug; 179(15):4859-67. PubMed ID: 9244275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATP citrate lyase: A central metabolic enzyme in cancer.
    Icard P; Wu Z; Fournel L; Coquerel A; Lincet H; Alifano M
    Cancer Lett; 2020 Feb; 471():125-134. PubMed ID: 31830561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyamine regulating protein antizyme binds to ATP citrate lyase to accelerate acetyl-CoA production in cancer cells.
    Tajima A; Murai N; Murakami Y; Iwamoto T; Migita T; Matsufuji S
    Biochem Biophys Res Commun; 2016 Mar; 471(4):646-51. PubMed ID: 26915799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATP citrate lyase knockdown induces growth arrest and apoptosis through different cell- and environment-dependent mechanisms.
    Zaidi N; Royaux I; Swinnen JV; Smans K
    Mol Cancer Ther; 2012 Sep; 11(9):1925-35. PubMed ID: 22718913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATP citrate lyase (ACLY) inhibitors: An anti-cancer strategy at the crossroads of glucose and lipid metabolism.
    Granchi C
    Eur J Med Chem; 2018 Sep; 157():1276-1291. PubMed ID: 30195238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ATP citrate lyase (ACLY): a promising target for cancer prevention and treatment.
    Khwairakpam AD; Shyamananda MS; Sailo BL; Rathnakaram SR; Padmavathi G; Kotoky J; Kunnumakkara AB
    Curr Drug Targets; 2015; 16(2):156-63. PubMed ID: 25537655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of hydroxycitrate to human ATP-citrate lyase.
    Hu J; Komakula A; Fraser ME
    Acta Crystallogr D Struct Biol; 2017 Aug; 73(Pt 8):660-671. PubMed ID: 28777081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allosteric role of the citrate synthase homology domain of ATP citrate lyase.
    Wei X; Schultz K; Pepper HL; Megill E; Vogt A; Snyder NW; Marmorstein R
    Nat Commun; 2023 Apr; 14(1):2247. PubMed ID: 37076498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ATP-citrate lyase regulates cellular senescence via an AMPK- and p53-dependent pathway.
    Lee JH; Jang H; Lee SM; Lee JE; Choi J; Kim TW; Cho EJ; Youn HD
    FEBS J; 2015 Jan; 282(2):361-71. PubMed ID: 25367309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.